1-10 of 10
D. Willem Erkelens
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Common Cholesteryl Ester Transfer Protein Gene Polymorphisms and the Effect of Atorvastatin Therapy in Type 2 Diabetes

Francine V. van Venrooij, MD, PHD, Ronald P. Stolk, PHD, Jan-Dirk Banga, MD, PHD, Tjeerd P. Sijmonsma, Arie van Tol, PHD, D. Willem Erkelens, MD, PHD, Geesje M. Dallinga-Thie, PHD, for the DALI study group
Journal: Diabetes Care
Diabetes Care 2003;26(4):1216–1223
https://doi.org/10.2337/diacare.26.4.1216
Published: 01 April 2003
View article titled, Common Cholesteryl Ester Transfer Protein Gene Polymorphisms and the Effect of Atorvastatin Therapy in Type 2 Diabetes
Open the PDF for Common Cholesteryl Ester Transfer Protein Gene Polymorphisms and the Effect of Atorvastatin Therapy in Type 2 Diabetes in another window
Journal Articles

Additional Lunchtime Basal Insulin During Insulin Lispro Intensive Therapy in a Randomized, Multicenter, Crossover Study in Adults : A real-life design

Aline M.E. Stades, MD, Joost B.L. Hoekstra, MD, PHD, Ingeborg van den Tweel, D. Willem Erkelens, MD, PHD, Frits Holleman, MD, PHD, STABILITY Study Group
Journal: Diabetes Care
Diabetes Care 2002;25(4):712–717
https://doi.org/10.2337/diacare.25.4.712
Published: 01 April 2002
View article titled, Additional Lunchtime Basal Insulin During Insulin Lispro Intensive Therapy in a Randomized, Multicenter, Crossover Study in Adults : <subtitle>A real-life design </subtitle>
Open the PDF for Additional Lunchtime Basal Insulin During Insulin Lispro Intensive Therapy in a Randomized, Multicenter, Crossover Study in Adults : <subtitle>A real-life design </subtitle> in another window
Journal Articles

The Sulfonylurea Glyburide Induces Impairment of Glucagon and Growth Hormone Responses During Mild Insulin-Induced Hypoglycemia

Edith W.M.T. ter Braak, MD, PHD, Alexander M.M.F. Appelman, MSC, Ingeborg van der Tweel, D. Willem Erkelens, MD, PHD, Timon W. van Haeften, MD, PHD
Journal: Diabetes Care
Diabetes Care 2002;25(1):107–112
https://doi.org/10.2337/diacare.25.1.107
Published: 01 January 2002
View article titled, The Sulfonylurea Glyburide Induces Impairment of Glucagon and Growth Hormone Responses During Mild Insulin-Induced Hypoglycemia
Open the PDF for The Sulfonylurea Glyburide Induces Impairment of Glucagon and Growth Hormone Responses During Mild Insulin-Induced Hypoglycemia in another window
Journal Articles

Insulin Secretion in Normal Glucose-Tolerant Relatives of Type 2 Diabetic Subjects: Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests

Timon W van Haeften, MD, PHD, Suzanne Dubbeldam, Maria L Zonderland, PHD, D Willem Erkelens, MD, PHD
Journal: Diabetes Care
Diabetes Care 1998;21(2):278–282
https://doi.org/10.2337/diacare.21.2.278
Published: 01 February 1998
View article titled, Insulin Secretion in Normal Glucose-Tolerant Relatives of Type 2 Diabetic Subjects: Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests
Open the PDF for Insulin Secretion in Normal Glucose-Tolerant Relatives of Type 2 Diabetic Subjects: Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests in another window
Journal Articles

Injection Site Effects on the Pharmacokinetics and Glucodynamics of Insulin Lispro and Regular Insulin

Edith W Ter Braak, MD, James R Woodworth, PHD, Rutgert Bianchi, MD, Benito Cerimele, PHD, D Willem Erkelens, MD, PHD, Jos H H Thijssen, PHD, Darcie Kurtz, MS
Journal: Diabetes Care
Diabetes Care 1996;19(12):1437–1440
https://doi.org/10.2337/diacare.19.12.1437
Published: 01 December 1996
View article titled, Injection Site Effects on the Pharmacokinetics and Glucodynamics of Insulin Lispro and Regular Insulin
Open the PDF for Injection Site Effects on the Pharmacokinetics and Glucodynamics of Insulin Lispro and Regular Insulin in another window
Journal Articles

Comparison of LysB28, ProB29-Human Insulin Analog and Regular Human Insulin in the Correction of Incidental Hyperglycemia

Frits Holleman, MD, Joop JG Van Den Brand, MSC, Roland ARA Hoven, MSC, Jos M Van Der Linden, MA, Ingeborg Van Der Tweel, Joost B L Hoekstra, MD, PHD, D Willem Erkelens, MD, PHD
Journal: Diabetes Care
Diabetes Care 1996;19(12):1426–1429
https://doi.org/10.2337/diacare.19.12.1426
Published: 01 December 1996
View article titled, Comparison of Lys<sup>B28</sup>, Pro<sup>B29</sup>-Human Insulin Analog and Regular Human Insulin in the Correction of Incidental Hyperglycemia
Open the PDF for Comparison of Lys<sup>B28</sup>, Pro<sup>B29</sup>-Human Insulin Analog and Regular Human Insulin in the Correction of Incidental Hyperglycemia in another window
Journal Articles

Effects of Low-Dose EPA-E on Glycemic Control, Lipid Profile, Lipoprotein(a), Platelet Aggregation, Viscosity, and Platelet and Vessel Wall Interaction in NIDDM

H Tineke Westerveld, MD, Jacques C de Graaf, MD, Hans HFI Van Breugel, PHD, Jan Willem N Akkerman, PHD, Jan J Sixma, MD, PHD, D Willem Erkelens, MD, PHD, Jan Dirk Banga, MD, PHD
Journal: Diabetes Care
Diabetes Care 1993;16(5):683–688
https://doi.org/10.2337/diacare.16.5.683
Published: 01 May 1993
View article titled, Effects of Low-Dose EPA-E on Glycemic Control, Lipid Profile, Lipoprotein(a), Platelet Aggregation, Viscosity, and Platelet and Vessel Wall Interaction in NIDDM
Open the PDF for Effects of Low-Dose EPA-E on Glycemic Control, Lipid Profile, Lipoprotein(a), Platelet Aggregation, Viscosity, and Platelet and Vessel Wall Interaction in NIDDM in another window
Journal Articles

Effects of Benfluorex on Insulin Resistance and Lipid Metabolism in Obese Type II Diabetic Patients

Rutgert Bianchi, MD, Vivian Bongers, Bert Bravenboer, MD, D Willem Erkelens, MD
Journal: Diabetes Care
Diabetes Care 1993;16(4):557–559
https://doi.org/10.2337/diacare.16.4.557
Published: 01 April 1993
View article titled, Effects of Benfluorex on Insulin Resistance and Lipid Metabolism in Obese Type II Diabetic Patients
Open the PDF for Effects of Benfluorex on Insulin Resistance and Lipid Metabolism in Obese Type II Diabetic Patients in another window
Journal Articles

Elevated Cholesteryl Ester Transfer Protein Activity in IDDM Men Who Smoke: Possible Factor for Unfavorable Lipoprotein Profile

Robin P F Dullaart, MD, Johanna E M Groener, PhD, Bert D Dikkeschei, PhD, D Willem Erkelens, MD, Hieronymus Doorenbos, MD
Journal: Diabetes Care
Diabetes Care 1991;14(4):338–341
https://doi.org/10.2337/diacare.14.4.338
Published: 01 April 1991
View article titled, Elevated Cholesteryl Ester Transfer Protein Activity in IDDM Men Who Smoke: Possible Factor for Unfavorable Lipoprotein Profile
Open the PDF for Elevated Cholesteryl Ester Transfer Protein Activity in IDDM Men Who Smoke: Possible Factor for Unfavorable Lipoprotein Profile in another window
Journal Articles

C-Peptide Reactivity as a Measure of Insulin Dependency in Obese Diabetic Patients Treated with Insulin

Joost B L Hoekstra, Herman J M Van Rijn, Joseph H H Thijssen, D Willem Erkelens
Journal: Diabetes Care
Diabetes Care 1982;5(6):585–591
https://doi.org/10.2337/diacare.5.6.585
Published: 01 November 1982
View article titled, C-Peptide Reactivity as a Measure of Insulin Dependency in Obese Diabetic Patients Treated with Insulin
Open the PDF for C-Peptide Reactivity as a Measure of Insulin Dependency in Obese Diabetic Patients Treated with Insulin in another window